Crowdonomics
All companies
RECOMPOSE logo

RECOMPOSE

Operating

Recompose, PBC

Healthcare

Carbon-sequestering green funeral solution that returns us to the earth

Post-money valuation ⓘ
$78.2M
As of Sep 2023 · from Reg CF Offering (2023) · pre-money + amount raised, not a traded price
Total raised
$6,200,478
Crowd $2.2M · Private $4.0M · 5 rounds since 2017
Latest share price
$4.71
Reg CF · Preferred Stock · Mar 2023 offering price

Financials

FY2020–FY2023 · from SEC filings · hover any figure for its source
$108K
−$1.1M
2020
$699K
−$1.5M
2021
$837K
−$3.8M
2022
$1.2M
−$4.4M
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020 audited
FY2021 audited
FY2022 audited
FY2023 audited
Income statement
Revenue
$107,645
$699,470
$836,764
$1,184,114
Cost of goods sold
$4,774
$236,604
$443,897
$428,156
Gross margin
96%
66%
47%
64%
Net income
-$1,138,234
-$1,468,252
-$3,757,981
-$4,381,409
Taxes paid
$0
$0
$0
$0
Balance sheet
Cash
$4,054,791
$7,482,622
$2,305,867
$2,607,580
Accounts receivable
$324,621
$560,088
$509,073
$745,863
Total assets
$7,596,083
$16,234,910
$24,920,885
$26,404,670
Short-term debt
$108,909
$512,621
$1,018,079
$706,154
Long-term debt
$2,059,104
$5,478,210
$14,067,005
$16,841,762
Total liabilities
$2,168,013
$5,990,831
$15,085,084
$17,547,916
Other
Headcount
—
16
—
17

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$76.1M
pre-money
Reg CF · Preferred · Mar 2023

Blue bars are the pre-money valuation the company stated for a priced round.

Fundraising history

Raised $2.2M / $5MInvestors 864Post-money $78.2M
Raised $91KInvestors 2
Raised $4MInvestors 40

Team

3 people
Katrina SpadeFounder
Founder and CEO
Leslie Christian
Board Member
Sara Hobart Moorehead
Director

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFiled Form C-TR (terminated reporting)

Filed 1 of 4 annual reports (FY2022–FY2025)

864 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

  • Form C-TROct 2, 20250001670254-25-000837
    EDGAR
  • Form DSep 10, 20250001707734-25-000002
    EDGAR
  • Form C-ARJan 29, 20250001670254-25-000032
    EDGAR
  • Form C/ASep 6, 20230001670254-23-000837
    EDGAR
  • Form C/AApr 25, 20230001670254-23-000395
    EDGAR
  • Form CMar 20, 20230001670254-23-000250
    EDGAR
  • Form DJun 16, 20210001707734-21-000001
    EDGAR
  • Form D/AMay 15, 20200001707734-20-000001
    EDGAR
Source: ManualCIK 0001707734Share price $4.71

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.